Page Content
#ffffff
Anonymous user
On
Authenticated user
On
Premium
On
Paid / Sponsored
On
Forrest JK, Yakubov SJ, Deeb GM, et al. 5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis. J Am Coll Cardiol. 2025;85(15):1523-1532. doi:10.1016/j.jacc.2025.03.004
EVOLUT LOW RISK TRIAL assessed the 5-year clinical and hemodynamic outcomes of transcatheter aortic valve replacement (TAVR) compared to surgical aortic valve replacement (SAVR) in patients enrolled in the Evolut Low Risk trial.